Healthcare -
Biotechnology - NASDAQ - US
$ 4.525
-6.7 %
$ 252 M
Market Cap
-2.45
P/E
FHTX - STOCK-BASED COMPENSATION
Stock-based Compensation FHTX - Foghorn Therapeutics Inc.
16.2 M
LAST VALUE
38.95%
2 YEAR CAGR
85.75%
5 YEAR CAGR
0.00%
10 YEAR CAGR